Literature DB >> 26587441

Decline of Renal Function and Progression of Left Ventricular Hypertrophy Are Independently Determined in Chronic Kidney Disease Stages 3-5.

Hiromichi Suzuki1, Tsutomu Inoue1, Mami Dogi2, Tomohiro Kikuta1, Tsuneo Takenaka3, Hirokazu Okada1.   

Abstract

UNLABELLED: Invasive and noninvasive methods for evaluating the effects of hemodynamics on progression of left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD) have been proposed. Central aortic pressure (CAP) has been reported to be the best among selected measures of hemodynamics for predicting LVH. However, there are few studies examining the relation between longitudinal changes in CAP and renal dysfunction in patients with CKD.
METHODS: Sixty-seven patients with CKD stages 3-5 (female/male ratio: 26/41, age: 61.5 ± 13.1 years) were followed for 5 years. Before and at the end of the 5-year period, CAP was recorded by an automated tonometric system (HEM-9000 AI; Omron Healthcare, Kyoto, Japan). Second systolic aortic blood pressure (SBP2) was employed as an index of CAP.
RESULTS: Throughout the study, systolic blood pressure (SBP) was well controlled. Renal function followed by estimated glomerular filtration rate (eGFR) gradually worsened as a whole. Ten patients had renal replacement therapy, 3 patients developed cardiovascular diseases and 2 patients were found to have a neoplasm during the 5-year observation period. SBP2 increased from 120 ± 19 to 125 ± 33 mm Hg and eGFR decreased from 38.2 ± 18.2 to 29.5 ± 16.3 ml/min/1.73 m(2); however, these differences did not achieve significance. The left ventricular mass (LVM) index significantly increased from 115.5 ± 10.5 to 131.2 ± 11.7 g/m(2) (p < 0.05). Although the changes in SBP2 and eGFR looked like a mirror image, there was no significant correlation between the two factors. Moreover, multivariate regression analysis did not reveal a close correlation between SBP2 and CKD progression. In contrast to the decline of renal function, the baseline value of SBP2 predicted an increase in the LVM index.
CONCLUSION: Worsening of renal dysfunction is not solely dependent on hemodynamics. Other factors might be involved in a complex manner.

Entities:  

Keywords:  Blood pressure; Central aortic pressure; Estimated glomerular filtration rate; Pulse wave velocity

Year:  2014        PMID: 26587441      PMCID: PMC4646155          DOI: 10.1159/000368678

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  24 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.

Authors:  Maarten W Taal; Mhairi K Sigrist; Apostolos Fakis; Richard J Fluck; Christopher W McIntyre
Journal:  Nephron Clin Pract       Date:  2007-11-01

Review 3.  Left ventricular mass in chronic kidney disease and ESRD.

Authors:  Richard J Glassock; Roberto Pecoits-Filho; Silvio H Barberato
Journal:  Clin J Am Soc Nephrol       Date:  2009-12       Impact factor: 8.237

4.  Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.

Authors:  Pierre Boutouyrie; Assya Achouba; Patrick Trunet; Stéphane Laurent
Journal:  Hypertension       Date:  2010-04-19       Impact factor: 10.190

5.  Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.

Authors:  Costas Tsioufis; Elena Vezali; Dimitris Tsiachris; Kyriakos Dimitriadis; Eystathios Taxiarchou; Dimitris Chatzis; Costas Thomopoulos; Dimitris Syrseloudis; Elli Stefanadi; Costas Mihas; Vicky Katsi; Vasilios Papademetriou; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2009-04       Impact factor: 4.844

6.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

7.  Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.

Authors:  Michael E Seifert; Lisa de las Fuentes; Marcos Rothstein; Dennis J Dietzen; Andrew J Bierhals; Steven C Cheng; Will Ross; David Windus; Víctor G Dávila-Román; Keith A Hruska
Journal:  Am J Nephrol       Date:  2013-08-07       Impact factor: 3.754

8.  Association of pulse wave velocity and pulse pressure with decline in kidney function.

Authors:  Chang Seong Kim; Ha Yeon Kim; Yong Un Kang; Joon Seok Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-10       Impact factor: 3.738

9.  Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.

Authors:  Kosaku Nitta; Satoshi Iimuro; Enyu Imai; Seiichi Matsuo; Hirofumi Makino; Tadao Akizawa; Tsuyoshi Watanabe; Yasuo Ohashi; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2013-01-16       Impact factor: 2.801

Review 10.  Arterial Stiffness, Kidney Function, and Chronic Kidney Disease Progression.

Authors:  Raymond R Townsend; Hirofumi Tomiyama
Journal:  Pulse (Basel)       Date:  2013-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.